choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Lyme Disease Drugs

Lyme Disease Drugs Newsletter
  • WSU Researcher Awarded $2.7M to Study Lyme Disease 19 Sep 2024 23:24 GMT

    … to treat disease. Transmitted through tick bites, early symptoms of Lyme disease often … the eventual development of new vaccines and treatment options for Lyme disease.” For the …

  • F.D. Flam: The first Lyme disease vaccine failed. It’s time to try again 18 Sep 2024 19:44 GMT

    … people don’t develop natural immunity to Lyme disease. We can … focusing on an antibody treatment that protects people almost … with Tarsus Pharmaceuticals by repurposing anti-tick medications used for … to eradicate Borrelia by treating wild mice with antibiotics …

  • Large-Scale Study Will Seek to Unearth Causes of Persistent Symptoms of Lyme Disease 17 Sep 2024 19:04 GMT

    … go on to develop debilitating symptoms later on. While Lyme disease often resolves … the fundamentals of post-treatment Lyme disease syndrome or chronic Lyme disease remain elusive. There … to good health and others develop prolonged symptoms. The study will …

  • Without a Lyme Disease Vaccine, the U.S. CDC Offers Information Toolkit 09 Sep 2024 22:56 GMT

    … today announced it has developed a new toolkit to … symptoms and concerns about Lyme disease, and review new clinical … Lyme disease in the U.S. While most patients recover fully after treatment … furthest along the clinical development timeline, with two Phase …

  • Lyme Disease Treatment Market: Valued at $737.5M and Projected to Double by 2031 | CAGR of 8.4% 09 Sep 2024 17:17 GMT

    treatments, various pharmaceutical companies are collaborating to develop vaccines against chronic Lyme disease. … a phase two trial of their Lyme disease vaccine candidate, VLA15 … the efficacy of medications like doxycycline against Lyme disease and other …

  • Pfizer/Valneva share promising results for Lyme disease vaccine candidate 06 Sep 2024 11:34 GMT

    … their Lyme disease vaccine candidate. The phase 2 VLA15-221 trial randomised … been observed in any treatment or age group to … and head vaccine research and development at Pfizer, said: “Personal … the US Food and Drug Administration and European Medicines …

  • Valneva, Pfizer report positive phase 2 booster results for Lyme disease vaccine candidate 06 Sep 2024 08:14 GMT

    Lyme disease vaccine candidate which has advanced the furthest along the clinical development … Monitoring Committee (DMC) in any treatment or age group. “Personal preventive … to the US Food and Drug Administration (FDA) and Marketing Authorization Application …

  • FDA grants clearance to new Lyme disease test 05 Sep 2024 07:08 GMT

    The US Food and Drug Administration (FDA) has cleared its new Lyme disease test, announces … ImmunoBlot strips in its laboratory-developed Lyme ImmunoBlot IgG assay. Key … only FDA-cleared Lyme serological test that includes these bands. Lyme disease is …

  • New Lyme Disease Test Could Deliver Results in 20 Minutes 04 Sep 2024 19:01 GMT

    Photo Credit: Smileus An improved test for Lyme disease could provide accurate results within 20 minutes, researchers report. The test—which resembles an AI-guided form of the at-home COVID-19 test— would be a vast improvement over the current two-part lab …

  • New treatments for migraine … and other research 12 Sep 2024 11:24 GMT

    … whom two to four preventive treatments had failed. Those given … by lifting heavy parcels of Lyme disease vectors—it might sound … with a three-in-one pill containing low dose telmisartan, … (none of the trial participants stopped any medications due to adverse …

Satisfied with the content?

Continue to create your account.